Literature DB >> 11180166

K-ras mutations in endometrial carcinomas with microsatellite instability.

H Lagarda1, L Catasus, R Arguelles, X Matias-Guiu, J Prat.   

Abstract

K-ras mutations are known to occur in hyperplasias and carcinomas of the endometrium. No clear correlation has been found yet between K-ras mutations and microsatellite instability (MI) in these lesions. Fifty-eight endometrial carcinomas (ECs) and 22 endometrial hyperplasias (EHs) were analysed for K-ras mutation by single-strand conformational polymorphism analysis (SSCP), restriction analysis, and DNA sequencing. MI status had been established previously at five dinucleotide loci and was reconfirmed with markers BAT-25 and BAT-26 by SSCP. K-ras mutations were detected in 11 ECs (18.9%). All 11 tumours were endometrioid carcinomas. K-ras mutations were more frequent in MI-positive (6/14, 42.8%) than in MI-negative tumours (5/44, 11.3%) (p=0.017). Methylation-related transitions were detected in five of the six MI-positive tumours but in only one of the five MI-negative carcinomas. K-ras mutation was identified in only one atypical EH (1/22, 4.5%); in this case, the EH co-existed with EC and both lesions exhibited MI. The results support a close relationship between K-ras mutations and the phenomenon of MI in endometrial carcinomas. The frequent occurrence of methylation-related transitions in these tumours may indicate a cause-effect relationship with the altered methylation status which has been described in association with MI.

Entities:  

Mesh:

Year:  2001        PMID: 11180166     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH769>3.0.CO;2-9

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  16 in total

1.  Identification of potential serum markers for endometrial cancer using protein expression profiling.

Authors:  Masashi Takano; Yoshihiro Kikuchi; Takayoshi Asakawa; Tomoko Goto; Tsunekazu Kita; Kazuya Kudoh; Junzo Kigawa; Noriaki Sakuragi; Masaru Sakamoto; Toru Sugiyama; Nobuo Yaegashi; Hiroshi Tsuda; Hiroshi Seto; Mieko Shiwa
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-16       Impact factor: 4.553

2.  Two cases of low-grade endometriod carcinoma associated with undifferentiated carcinoma of the uterus (dedifferentiated carcinoma): a molecular study.

Authors:  Giovanna Giordano; Tiziana D'Adda; Lorena Bottarelli; Mariano Lombardi; Francesca Brigati; Roberto Berretta; Carla Merisio
Journal:  Pathol Oncol Res       Date:  2011-03-30       Impact factor: 3.201

3.  High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases.

Authors:  Anita Steinbakk; Anais Malpica; Aida Slewa; Einar Gudlaugsson; Emiel A M Janssen; Mark Arends; Arnold Jan Kruse; Yu Yinhua; Weiwei Feng; Jan P Baak
Journal:  Cell Oncol (Dordr)       Date:  2011-05-06       Impact factor: 6.730

4.  KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels.

Authors:  David Llobet; Nuria Eritja; Monica Domingo; Laura Bergada; Cristina Mirantes; Maria Santacana; Judit Pallares; Anna Macià; Andree Yeramian; Mario Encinas; Gema Moreno-Bueno; Jose Palacios; Robert E Lewis; Xavier Matias-Guiu; Xavi Dolcet
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

5.  Controversies in the management of endometrial carcinoma.

Authors:  Ying Zhang; Jian Wang
Journal:  Obstet Gynecol Int       Date:  2010-06-22

6.  DcR1 expression in endometrial carcinomas.

Authors:  Jordi Tarragona; Nuria Llecha; Maria Santacana; Susana Lopez; Sonia Gatius; David Llobet; Xavier Dolcet; Victor Palomar-Asenjo; Francisco Javier Gonzalez-Tallada; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2009-11-20       Impact factor: 4.064

7.  Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract.

Authors:  Jelena Mirkovic; Lynette M Sholl; Elizabeth Garcia; Neal Lindeman; Laura MacConaill; Michelle Hirsch; Paola Dal Cin; Melissa Gorman; Justine A Barletta; Marisa R Nucci; W Glenn McCluggage; Brooke E Howitt
Journal:  Mod Pathol       Date:  2015-09-04       Impact factor: 7.842

Review 8.  Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.

Authors:  Tanri Shiozawa; Ikuo Konishi
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.850

9.  K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene.

Authors:  T Hachisuga; H Tsujioka; S Horiuchi; T Udou; M Emoto; T Kawarabayashi
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

Review 10.  Molecular alterations of PI3K/Akt/mTOR pathway: a therapeutic target in endometrial cancer.

Authors:  Athanasia Pavlidou; Nikos F Vlahos
Journal:  ScientificWorldJournal       Date:  2014-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.